• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

The new implantable device for chronic pain management is small and flexible.© The Zhou Lab at University of Southern California

Wireless implant breakthrough offers personalised chronic pain relief

, 4 July 2025/in E-News, Prosthetics, Research /by panglobal

Researchers at the University of Southern California have developed a revolutionary wireless implant that could transform chronic pain management for millions of patients. The ultrasound-induced wireless implantable (UIWI) stimulator combines artificial intelligence with flexible bioelectronics to deliver personalised spinal cord stimulation without requiring batteries or invasive surgical procedures.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/07/device.jpg 758 1048 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-04 08:00:132025-07-01 11:30:55Wireless implant breakthrough offers personalised chronic pain relief
Professor Bin He from Carnegie Mellon University’s Department of Biomedical Engineering.

EEG-powered brain computer interface enables finger-level robotic hand control

BCI, EEG, 3 July 2025/in E-News, Prosthetics /by panglobal

Carnegie Mellon University scientists have demonstrated the first noninvasive brain-computer interface capable of controlling individual robotic fingers in real-time using electroencephalography (EEG) signals. The breakthrough study, involving 21 participants, achieved 80.56% accuracy for two-finger control tasks and represents a significant advance in dexterous robotic manipulation through thought alone. .

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/07/Bin_He.jpg 1336 1558 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-03 08:00:412025-07-01 11:54:28EEG-powered brain computer interface enables finger-level robotic hand control
Researchers have discovered a molecular fingerprint called the “traumome”

Scientists identify ‘traumome’ targets for rapid emergency trauma treatment

molecular medicine, trauma, traumome, 2 July 2025/in E-News, Editors' Picks, Research /by panglobal

Researchers have discovered a molecular fingerprint called the “traumome” that becomes accessible within minutes of severe injury. The breakthrough could enable targeted treatments to be delivered directly to trauma sites, with the potential to significantly advance emergency trauma care for patients with life-threatening injuries.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/06/trauma.jpg 829 1244 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-02 19:10:192025-06-27 13:43:58Scientists identify ‘traumome’ targets for rapid emergency trauma treatment
The BMJ has uncovered substantial data integrity concerns surrounding ticagrelor

BMJ investigation reveals AstraZeneca’s billion-dollar heart drug built on flawed data

AstraZeneca, BMJ, ticagrelor, 1 July 2025/in E-News, pharmacology, Research /by panglobal

A damning BMJ investigation has blown open a scandal at the heart of modern cardiology, revealing how AstraZeneca’s billion-dollar blockbuster ticagrelor may have reached patients through manipulated data, missing evidence, and phantom investigators in clinical trials that regulators failed to properly scrutinise.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/07/blood.jpg 281 500 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-07-01 11:13:022025-07-01 11:13:02BMJ investigation reveals AstraZeneca’s billion-dollar heart drug built on flawed data
healthcare LLM AI bias women patients

Healthcare LLM AI systems show dangerous bias against women patients

LLMs, patient safety, 26 June 2025/in AI, E-News /by panglobal

Large Language Model  (LLM) artificial intelligence systems increasingly deployed across healthcare settings pose serious risks to patient safety, with new research revealing these tools systematically recommend reduced medical care for women and vulnerable populations based on irrelevant factors such as typing errors and communication style rather than clinical need.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/06/AI-and-human.jpg 538 960 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-06-26 09:53:222025-06-26 09:53:22Healthcare LLM AI systems show dangerous bias against women patients
HLTH Europe 2025

HLTH Europe: Healthcare reimagined

HLTH Europe 2025, 24 June 2025/in E-News, Events /by panglobal

HLTH Europe represents a paradigm shift in healthcare innovation conferences, establishing itself as the continent’s premier forum for addressing complex systemic challenges across the medical ecosystem. Held 15-18 June at Amsterdam’s RAI Convention Centre, this landmark event brought together more than 5,000 attendees from 50+ countries to tackle healthcare’s most pressing issues through collaborative innovation. […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/06/hlth_IMG_6023-e1750764937482.jpg 640 480 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-06-24 11:43:582025-06-24 11:43:58HLTH Europe: Healthcare reimagined
Philips Future Health Index 2025

Philips Future Health Index report reveals healthcare AI trust gap

Philips, 24 June 2025/in AI, E-News /by panglobal

A comprehensive global survey commissioned by Philips has identified substantial trust disparities between healthcare professionals and patients regarding artificial intelligence implementation in medical care, with professionals showing significantly greater optimism about AI’s potential to improve patient outcomes. 

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/06/phlips-future-health-index-report-2025.jpg 1322 2358 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-06-24 11:25:192025-06-24 11:25:19Philips Future Health Index report reveals healthcare AI trust gap

Novel synthetic compound shows promise against drug-resistant bacteria

AMR, antibiotic resistance, infuzide, 23 June 2025/in E-News, pharmacology /by panglobal

Researchers have developed a novel synthetic compound called infuzide that shows promising activity against multidrug-resistant bacterial infections. The compound demonstrated effectiveness against resistant strains of Staphylococcus aureus and Enterococcus species in both laboratory and mouse studies, potentially offering a new therapeutic approach for treating serious hospital-acquired infections.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/06/Molecule-scaled.png 1652 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-06-23 11:14:282025-06-23 11:14:28Novel synthetic compound shows promise against drug-resistant bacteria
Fujifilm SYNAPSE Pathology

Fujifilm partners with Ibex for AI-powered cancer diagnostics

FUJIFILM, 23 June 2025/in E-News, Oncology /by panglobal

FUJIFILM Healthcare Europe has announced a formal partnership with Ibex Medical Analytics to integrate artificial intelligence-powered cancer diagnostics into digital pathology workflows, addressing the critical shortage of pathologists whilst enhancing diagnostic accuracy and efficiency.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/06/FUJIFILM-Healthcare-Europe-IBEX.png 810 1440 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-06-23 10:43:312025-06-23 10:43:31Fujifilm partners with Ibex for AI-powered cancer diagnostics
The BCI study participantUC Regents

Neuroprosthetics breakthrough: brain implant enables real-time speech synthesis for ALS patient

rehabilitation, 19 June 2025/in E-News, Neurology, Prosthetics /by panglobal

Researchers at UC Davis have demonstrated the first brain-computer interface that directly translates neural activity into synthesised speech in real-time, allowing a man with severe ALS to communicate naturally with immediate audio feedback rather than text-based approaches.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/06/BCI_1.jpg 2000 1500 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-06-19 11:32:232025-06-19 11:32:23Neuroprosthetics breakthrough: brain implant enables real-time speech synthesis for ALS patient
Page 3 of 233‹12345›»

Latest issue of International Hospital

April 2024

8 August 2025

NEFECON receives Chinese approval for expanded IgA nephropathy treatment

7 August 2025

25-year study reveals how SuperAgers defy cognitive decline

6 August 2025

15 minutes in city green space proves powerful antidote to anxiety and depression

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription